Literature DB >> 9786157

Lipomatous hypertrophy of the atrial septum: diagnosis with fat suppressed MR imaging.

K J Mortele1, P J Mergo, W F Williams.   

Abstract

We present a case of a 50-year-old female evaluated for a 1-year history of numbness of the first and second toe of the right foot. Echocardiography performed in order to exclude cardiovascular compromise revealed a granular mass originating from the posterior part of the interatrial septum. On subsequent magnetic resonance imaging (MRI) with fat suppression sequences, the final diagnosis of lipomatous hypertrophy of the interatrial septum, a benign and underrecognized condition characterized by septal accumulation of fatty tissue, was made. Although no previous reports have focused on this, tailored cardiac MR with fat suppression sequences proved to be an excellent noninvasive method in assessing an accurate diagnosis and in differentiating lipomatous hypertrophy of the atrial septum from other cardiac neoplasms.

Entities:  

Mesh:

Year:  1998        PMID: 9786157     DOI: 10.1002/jmri.1880080524

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  4 in total

1.  Can cardiac magnetic resonance imaging reliably differentiate between benign and neoplastic fat?

Authors:  Yang Faridah A Aziz; Paul R Julsrud
Journal:  Int J Cardiovasc Imaging       Date:  2002-06       Impact factor: 2.357

2.  Benign cardiac tumor in a patient with lung malignancy.

Authors:  F Dodos; T Schneider; J W U Fries; U C Hoppe
Journal:  Clin Res Cardiol       Date:  2007-08-13       Impact factor: 5.460

3.  71-year-old woman with dizziness and lipomatous hypertrophy of the left atrium.

Authors:  Philip Samuel Osbak; Klaus Fuglsang Kofoed
Journal:  BMJ Case Rep       Date:  2009-02-16

4.  MR first pass perfusion of benign and malignant cardiac tumours-significant differences and diagnostic accuracy.

Authors:  K U Bauner; S Sourbron; M Picciolo; C Schmitz; D Theisen; T A Sandner; M F Reiser; A M Huber
Journal:  Eur Radiol       Date:  2011-08-26       Impact factor: 5.315

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.